<?xml version="1.0" encoding="UTF-8"?>
<ref id="B94-ijms-19-00686" class="ref">
 <label class="label">94.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Menendez</surname>
    <given-names class="given-names">J.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Vazquez-Martin</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Colomer</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Brunet</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Carrasco-Pancorbo</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Garcia-Villalba</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Fernandez-Gutierrez</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Segura-Carretero</surname>
    <given-names class="given-names">A.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Olive oil’s bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells</article-title>
  <source class="source">BMC Cancer</source>
  <year class="year">2007</year>
  <volume class="volume">7</volume>
  <elocation-id class="elocation-id">80</elocation-id>
  <pub-id pub-id-type="doi" class="pub-id">10.1186/1471-2407-7-80</pub-id>
  <?supplied-pmid 17490486?>
  <pub-id pub-id-type="pmid" class="pub-id">17490486</pub-id>
 </element-citation>
</ref>
